Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label in the Record History updated from v3.5.3 to v3.5.4, indicating a small update to the site’s versioning metadata. The change does not modify the study data or primary content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov site revision number (from v3.5.2 to v3.5.3). This represents a platform/version update without changing the study record content shown on the page.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded a new revision entry v3.5.2 and removed the previous v3.5.0 entry from the history.SummaryDifference0.1%

- Check48 days agoChange DetectedDifference0.1%

- Check55 days agoChange DetectedThe version history shows updates to study status and recruitment/locations across multiple versions, with revised contact details for the study team. These changes reflect ongoing status updates for the trial and adjustments to access points for the site.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.